Stock Quote

Albemarle Corporation (ALB) (NYSE Arca)
As of  1:54pm EST
34.30USD
Price Change
+0.20
Percent Change
+0.59%
 
$34.30
1:54pm EST
+0.59%
$34.10
$34.83
285,741
$35.00
$34.15
$35.48
$15.54
1.52
559,157

Research Another Stock: Symbol Look-up
UPDATE 1-Albemarle profit down 7 pct in 3d quarter
Monday, 26 Oct 2009 05:37pm EDT 
UPDATE 1-Albemarle 2nd-qtr earnings down 38 percent
Wednesday, 22 Jul 2009 05:51pm EDT 
UPDATE 2-Goldman raises US specialty chemical sector
Friday, 15 May 2009 12:25pm EDT 
US RESEARCH SUMMARY-Non-S&P 500 May 1 1751 GMT
Friday, 1 May 2009 01:51pm EDT(RTRS) 
US RESEARCH SUMMARY-Non-S&P 500 May 1 1355 GMT
Friday, 1 May 2009 09:56am EDT(RTRS) 
Albemarle Corp. Q3 2009 Earnings Call Transcript
Tuesday, 27 Oct 2009 08:33pm EDT(Seeking Alpha) 
Updated Dividend Growers List from the S&P 1500
Sunday, 2 Aug 2009 04:42am EDT(Seeking Alpha) 
81 Dividend Growers To Consider
Wednesday, 24 Jun 2009 03:36am EDT(Seeking Alpha) 
Wall Street Breakfast: Must-Know News
Tuesday, 28 Apr 2009 07:19am EDT(SeekingAlpha) 
6 'Bathwater Babies' and 20 'Dogs with Fleas' for the Week
Monday, 16 Mar 2009 06:23am EDT(SeekingAlpha) 
 
Name Current Position Compensation
Rohr, Mark Chairman of the Board, President, Chief Executive Officer 6,603,410
Diemer, Richard Chief Financial Officer, Senior Vice President 2,265,870
Steitz, John Chief Operating Officer, Executive Vice President 2,920,060

Profile

Albemarle Corporation (Albemarle) is a global developer, manufacturer and marketer of engineered specialty chemicals. Albemarle sells a diversified mix of products to a range of customers, including manufacturers of consumer electronics, building and construction materials, automotive parts,... Full Description

Company Address

Albemarle Corporation
451 Florida Street,
Baton Rouge   LA   70801
P: +1225.3887402
F: +1255.3888924

Analyst Research

Performance of Key Competitors

Company Price Change
Israel Chemicals Limited ₪5,200.00 +115.00
Chemtura Corporation $0.76 -0.01
Nabaltec AG €4.51 +0.09
  ALB Industry
P/E(TTM) 24.30 0.26
P/S(TTM) 1.59 0.04
ROI(TTM) 4.91 0.01
ROE(TTM) 10.54 0.06
Consensus Recommendation Outperform
EPS Est. (Current Period) 0.58
EPS Est. (Current Year) 1.80
Total Revenue $515.28M
Net Income $51.52M
EPS $0.57